17/11/2025
Mastering Three Robotic Platforms for Re**al Cancer Surgery
One of the most interesting shifts in my practice at Apollo Hospitals over the last decade has been moving seamlessly across three different robotic platforms for re**al cancer surgery — the Intuitive da Vinci, Medtronic Robotic-Assisted Surgery Hugo RAS, and India’s own SS Innovations International, Inc. Mantra.
After completing 850+ robotic colore**al procedures, something becomes very clear.
If you build the right team with strong, generic robotic fundamentals — deep pelvic dissection, precise nerve preservation, clean mesore**al planes — the platform becomes a tool, not a barrier. Switching systems becomes second nature. The teamwork augments these transitions.
What each platform brings to the table:
*da Vinci*
Integrated platform
ICG for bowel perfusion
Robotic staplers ideal for ultra-low pelvic work
Outstanding precision for total mesore**al excision
*Hugo RAS*
Modular arms with flexible positioning
Open-console design that improves team communication
Medtronic portfolio of MIS instrumentation
*SSI Mantra*
India’s indigenous modular open system
Cost-efficient for large-scale adoption
Enables telesurgery, opening the door for equitable cancer care across India
Each system has its strengths. But the core principles of safe oncologic surgery remain the same.
Why multi-platform proficiency matters
It allows us at Apollo Hospitals to:
Choose the right system for the right patient
Build truly platform-generic robotic programmes
Train surgeons to be cost efficient, adaptable, thoughtful, and anatomy-driven
Expand advanced colore**al care across all Apollo units.
Most importantly, it helps us deliver consistent, high-quality outcomes, regardless of which platform is in the OR.
The Road Ahead:
With the rise of cost-efficient platforms like SS Innovations International, Inc. Mantra and the possibilities of telesurgery, India is on the brink of expanding access to complex re**al cancer surgery in a way